Literature DB >> 17154429

Ligand-based vascular targeting of disease.

Jascha-N Rybak1, Eveline Trachsel, Jörg Scheuermann, Dario Neri.   

Abstract

This review illustrates the basic principles of ligand-based vascular targeting and presents some of the most advanced results obtained in this field, not only in terms of biopharmaceuticals, which are currently being investigated in clinical and preclinical studies, but also in terms of enabling technologies that facilitate target and ligand discovery. Whereas most of the vascular targeting research activities have so far concentrated on tumoral angiogenesis, the development of non-oncological applications has recently gained momentum and is likely to become an important area of modern pharmaceutical research.

Mesh:

Substances:

Year:  2007        PMID: 17154429     DOI: 10.1002/cmdc.200600181

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  14 in total

1.  Driving delivery vehicles with ultrasound.

Authors:  Katherine W Ferrara
Journal:  Adv Drug Deliv Rev       Date:  2008-03-30       Impact factor: 15.470

Review 2.  Innovative proteomics for the discovery of systemically accessible cancer biomarkers suitable for imaging and targeted therapies.

Authors:  Andrei Turtoi; Edwin De Pauw; Vincent Castronovo
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 3.  Tenascin-C in cardiovascular remodeling: potential impact for diagnosis, prognosis estimation and targeted therapy.

Authors:  Marcus Franz; Christian Jung; Alexander Lauten; Hans R Figulla; Alexander Berndt
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

Review 4.  A physiological perspective on the use of imaging to assess the in vivo delivery of therapeutics.

Authors:  Shengping Qin; Brett Z Fite; M Karen J Gagnon; Jai W Seo; Fitz-Roy Curry; Frits Thorsen; Katherine W Ferrara
Journal:  Ann Biomed Eng       Date:  2013-09-10       Impact factor: 3.934

5.  Changes in extra cellular matrix remodelling and re-expression of fibronectin and tenascin-C splicing variants in human myocardial tissue of the right atrial auricle: implications for a targeted therapy of cardiovascular diseases using human SIP format antibodies.

Authors:  Marcus Franz; Bernhard R Brehm; Petra Richter; Katja Gruen; Dario Neri; Hartwig Kosmehl; Khosro Hekmat; Andre Renner; Jan Gummert; Hans R Figulla; Alexander Berndt
Journal:  J Mol Histol       Date:  2010-03-16       Impact factor: 2.611

6.  Comparative analysis of oncofetal fibronectin and tenascin-C expression in right atrial auricular and left ventricular human cardiac tissue from patients with coronary artery disease and aortic valve stenosis.

Authors:  Anja Baldinger; Bernhard R Brehm; Petra Richter; Torsten Bossert; Katja Gruen; Khosro Hekmat; Hartwig Kosmehl; Dario Neri; Hans-Reiner Figulla; Alexander Berndt; Marcus Franz
Journal:  Histochem Cell Biol       Date:  2011-04-10       Impact factor: 4.304

7.  F8-SIP mediated targeted photodynamic therapy leads to microvascular dysfunction and reduced glioma growth.

Authors:  G Acker; A Palumbo; D Neri; P Vajkoczy; M Czabanka
Journal:  J Neurooncol       Date:  2016-05-17       Impact factor: 4.130

8.  (124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy.

Authors:  Bernard M Tijink; Lars R Perk; Marianne Budde; Marijke Stigter-van Walsum; Gerard W M Visser; Reina W Kloet; Ludger M Dinkelborg; C René Leemans; Dario Neri; Guus A M S van Dongen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

9.  Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.

Authors:  J K J Ahlskog; C Schliemann; J Mårlind; U Qureshi; A Ammar; R B Pedley; D Neri
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

10.  Antibody-based delivery of interleukin-9 to neovascular structures: Therapeutic evaluation in cancer and arthritis.

Authors:  Baptiste Gouyou; Tiziano Ongaro; Samuele Cazzamalli; Roberto De Luca; Anne Kerschenmeyer; Philippe Valet; Alessandra Villa; Dario Neri; Mattia Matasci
Journal:  Exp Biol Med (Maywood)       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.